×

Lion Biotechnologies to Present at the Jefferies 2014 Global Healthcare Conference

LOS ANGELES, May 27, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs), today announced that Chief Executive Officer Manish Singh, Ph.D., will present at the Jefferies 2014 Global Healthcare Conference on Thursday, June 5, 2014, at 12:30 p.m. Eastern in Ballroom 1. The conference is being held at The Grand Hyatt Hotel, New York, from June 2-5, 2014.

A webcast of Dr. Singh's presentation will be available both live and on replay. The presentation will be available via webcast at http://wsw.com/webcast/jeff82/LBIO. A replay will also be available for 90 days following the live presentation. The live webcast and subsequent archived replay of Lion Biotechnologies' presentation will also be accessible via the Investors section of the Company's web site at http://lbio.com/investors/ under "Recent Events."

About Lion Biotechnologies

Lion Biotechnologies, Inc. is engaged in the development of T-cells and engineered T-cells for the treatment of various cancers. The company's lead product candidate is a ready-to-infuse autologous T-cell therapy utilizing tumor-infiltrating lymphocytes (TILs) for the treatment of patients with Stage IV metastatic melanoma, and is based on a clinical CRADA with the National Cancer Institute along with physician-sponsored investigational therapy at the MD Anderson Cancer Center and the H. Lee Moffitt Cancer & Research Institute. For more information, please visit http://www.lionbio.com.

CONTACT: Investor Relations The Trout Group Gitanjali Jain Ogawa 646-378-2949 gogawa@troutgroup.comSource:Lion Biotechnologies, Inc.